Kim K, Kwon H, Kim S, Oh S, Lee S, Lee J, et al. Prognostic significance of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in biliary tract cancer patients receiving adjuvant 5-fluorouracil-based chemotherapy. Mol Clin Oncol. 2013;1:987-994 pubmed

Ko J, Huang Y, Chen H, Tseng S, Chiu H, Wo T, et al. Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells. Basic Clin Pharmacol Toxicol. 2013;113:56-65 pubmed 出版商

Weng S, Tseng S, Huang Y, Chen H, Lin Y. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells. Biochem Pharmacol. 2012;84:126-36 pubmed 出版商

Weng S, Tsai M, Chiu Y, Kuo Y, Chen H, Lin Y. Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression. Basic Clin Pharmacol Toxicol. 2012;110:298-306 pubmed 出版商

Ko J, Tsai M, Chiu Y, Weng S, Kuo Y, Lin Y. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells. J Pharmacol Exp Ther. 2011;338:184-94 pubmed 出版商

Ko J, Tsai M, Kuo Y, Chiu Y, Weng S, Su Y, et al. Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine. Biochem Pharmacol. 2011;81:680-90 pubmed 出版商